Satellite Bio
Cambridge, US · Founded 2019 · 7 known investors
Find your way into Satellite Bio
177 people in our graph share verified history with the Satellite Bio team — schools, employers, funds. One of them is your warm intro.
Michelle Modestunlockedknows Christopher Chen · together at University of California, Santa Cruz (overlapped)
×10knows the team · via University of California, Santa Cruz
knows the team · via FedEx Office
Satellite Bio develops an off-the-shelf cell therapy that delivers functional liver cells (hepatocytes) into the body, where they engraft to restore liver function. The therapy targets patients with severe liver diseases and hepatic insufficiency who lack effective treatment options.
Founders & leadership
Satellite Bio was founded in 2019 by Christopher Chen.
CC
Christopher CheninFounderChristopher Chen is a recent graduate with coursework in mechanical and modern physics, multivariable calculus, and mathematical methods in the physical sciences. He has gained experience in data analysis and programming through Python coursework and laboratory work.
TL
Thomas LoweryExecutive
Board
EM
Ellie McGuireBoard director
LW
Ling WongBoard director
SB
Sujata BhatiaBoard director
WY
William YoungBoard director
Investors · 7
Reported raises · per SEC filings
Form D private placements▶$82.5MraisedMar 2022 · 10 investors · BiotechnologyRule 506(b)
▶$82.5MraisedMar 2022 · 10 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Eileen McGuireDirector
- David LennonExecutive Officer, Director
- Christopher ChenDirector, Promoter
- Ling WongDirector
- Yair SchindelDirector
- Sangeeta BhatiaPromoter
- William YoungDirector
- Laura Lande-DinerExecutive Officer
- Diane MarcouExecutive Officer
- Offering amount
- $100M
- Amount sold
- $82.5M
- First sale
- Feb 2022
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
▶$19MraisedNov 2020 · 7 investors · BiotechnologyRule 506(b)
▶$19MraisedNov 2020 · 7 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Ellie McGuireDirector
- Ling WongDirector
- Christopher ChenDirector, Promoter
- Sujata BhatiaDirector
- Sangeeta BhatiaPromoter
- Thomas LoweryExecutive Officer
- William YoungDirector
- Offering amount
- $19M
- Amount sold
- $19M
- First sale
- Nov 2020
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does Satellite Bio do?
- Satellite Bio develops an off-the-shelf cell therapy that delivers functional liver cells (hepatocytes) into the body, where they engraft to restore liver function. The therapy targets patients with severe liver diseases and hepatic insufficiency who lack effective treatment options.
- Who founded Satellite Bio?
- Satellite Bio was founded by Christopher Chen in 2019.
- Who are Satellite Bio's investors?
- Satellite Bio's investors include Alumni Ventures, aMoon, Catalio Capital Management, LP, Lightspeed Venture Partners, Highbury Holdings, Polaris Partners, S32.
- Where is Satellite Bio headquartered?
- Satellite Bio is headquartered in Cambridge, US.